1. Home
  2. RNXT vs ONMD Comparison

RNXT vs ONMD Comparison

Compare RNXT & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • ONMD
  • Stock Information
  • Founded
  • RNXT 2012
  • ONMD 2006
  • Country
  • RNXT United States
  • ONMD United States
  • Employees
  • RNXT N/A
  • ONMD N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • ONMD
  • Sector
  • RNXT Health Care
  • ONMD
  • Exchange
  • RNXT Nasdaq
  • ONMD Nasdaq
  • Market Cap
  • RNXT 44.6M
  • ONMD 12.8M
  • IPO Year
  • RNXT 2021
  • ONMD N/A
  • Fundamental
  • Price
  • RNXT $1.36
  • ONMD $0.56
  • Analyst Decision
  • RNXT Strong Buy
  • ONMD
  • Analyst Count
  • RNXT 2
  • ONMD 0
  • Target Price
  • RNXT $7.25
  • ONMD N/A
  • AVG Volume (30 Days)
  • RNXT 147.2K
  • ONMD 25.4M
  • Earning Date
  • RNXT 08-12-2025
  • ONMD 05-14-2025
  • Dividend Yield
  • RNXT N/A
  • ONMD N/A
  • EPS Growth
  • RNXT N/A
  • ONMD N/A
  • EPS
  • RNXT N/A
  • ONMD N/A
  • Revenue
  • RNXT $240,000.00
  • ONMD $532,000.00
  • Revenue This Year
  • RNXT $3,186.05
  • ONMD N/A
  • Revenue Next Year
  • RNXT $291.93
  • ONMD N/A
  • P/E Ratio
  • RNXT N/A
  • ONMD N/A
  • Revenue Growth
  • RNXT N/A
  • ONMD N/A
  • 52 Week Low
  • RNXT $0.75
  • ONMD $0.30
  • 52 Week High
  • RNXT $1.69
  • ONMD $1.60
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 55.76
  • ONMD 56.14
  • Support Level
  • RNXT $1.27
  • ONMD $0.34
  • Resistance Level
  • RNXT $1.42
  • ONMD $0.66
  • Average True Range (ATR)
  • RNXT 0.07
  • ONMD 0.09
  • MACD
  • RNXT -0.02
  • ONMD 0.02
  • Stochastic Oscillator
  • RNXT 62.50
  • ONMD 40.17

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.

Share on Social Networks: